-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Amneal will install dedicated manufacturing ...
The blow fill-seal technology market is evolving into a core sterile pharmaceutical manufacturing infrastructure, driven by automation, contamination control, and rising demand for unit-dose drug ...
The global pharmaceutical industry continues to evolve rapidly, placing greater emphasis on product safety, contamination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results